Matches in SemOpenAlex for { <https://semopenalex.org/work/W3213988224> ?p ?o ?g. }
- W3213988224 endingPage "5555" @default.
- W3213988224 startingPage "5555" @default.
- W3213988224 abstract "Splicing is an essential process wherein precursor messenger RNA (pre-mRNA) is reshaped into mature mRNA. In alternative splicing, exons of any pre-mRNA get rearranged to form mRNA variants and subsequently protein isoforms, which are distinct both by structure and function. On the other hand, aberrant splicing is the cause of many disorders, including cancer. In the past few decades, developments in the understanding of the underlying biological basis for cancer progression and therapeutic resistance have identified many oncogenes as well as carcinogenic splice variants of essential genes. These transcripts are involved in various cellular processes, such as apoptosis, cell signaling and proliferation. Strategies to inhibit these carcinogenic isoforms at the mRNA level are promising. Antisense oligonucleotides (AOs) have been developed to inhibit the production of alternatively spliced carcinogenic isoforms through splice modulation or mRNA degradation. AOs can also be used to induce splice switching, where the expression of an oncogenic protein can be inhibited by the induction of a premature stop codon. In general, AOs are modified chemically to increase their stability and binding affinity. One of the major concerns with AOs is efficient delivery. Strategies for the delivery of AOs are constantly being evolved to facilitate the entry of AOs into cells. In this review, the different chemical modifications employed and delivery strategies applied are discussed. In addition to that various AOs in clinical trials and their efficacy are discussed herein with a focus on six distinct studies that use AO-mediated exon skipping as a therapeutic strategy to combat cancer." @default.
- W3213988224 created "2021-11-22" @default.
- W3213988224 creator A5002306992 @default.
- W3213988224 creator A5009329097 @default.
- W3213988224 creator A5054694810 @default.
- W3213988224 creator A5086552206 @default.
- W3213988224 creator A5090103525 @default.
- W3213988224 date "2021-11-05" @default.
- W3213988224 modified "2023-10-16" @default.
- W3213988224 title "Antisense Oligonucleotide-Mediated Splice Switching: Potential Therapeutic Approach for Cancer Mitigation" @default.
- W3213988224 cites W108400146 @default.
- W3213988224 cites W122116900 @default.
- W3213988224 cites W135892607 @default.
- W3213988224 cites W145845885 @default.
- W3213988224 cites W1543222911 @default.
- W3213988224 cites W1670839080 @default.
- W3213988224 cites W1963042350 @default.
- W3213988224 cites W1963571549 @default.
- W3213988224 cites W1963868387 @default.
- W3213988224 cites W1963879883 @default.
- W3213988224 cites W1965758842 @default.
- W3213988224 cites W1967482611 @default.
- W3213988224 cites W1970605675 @default.
- W3213988224 cites W1974050574 @default.
- W3213988224 cites W1975294548 @default.
- W3213988224 cites W1978919947 @default.
- W3213988224 cites W1982827319 @default.
- W3213988224 cites W1983711895 @default.
- W3213988224 cites W1986912321 @default.
- W3213988224 cites W1987783626 @default.
- W3213988224 cites W1988610380 @default.
- W3213988224 cites W1990086381 @default.
- W3213988224 cites W1990507217 @default.
- W3213988224 cites W1994869675 @default.
- W3213988224 cites W1996860050 @default.
- W3213988224 cites W2001327335 @default.
- W3213988224 cites W2001603079 @default.
- W3213988224 cites W2002703021 @default.
- W3213988224 cites W2003642545 @default.
- W3213988224 cites W2004396300 @default.
- W3213988224 cites W2006167464 @default.
- W3213988224 cites W2006998980 @default.
- W3213988224 cites W2009082552 @default.
- W3213988224 cites W2009305757 @default.
- W3213988224 cites W2009482334 @default.
- W3213988224 cites W2014921813 @default.
- W3213988224 cites W2014975424 @default.
- W3213988224 cites W2016765784 @default.
- W3213988224 cites W2018625819 @default.
- W3213988224 cites W2026196315 @default.
- W3213988224 cites W2028016023 @default.
- W3213988224 cites W2031385493 @default.
- W3213988224 cites W2036077010 @default.
- W3213988224 cites W2038332844 @default.
- W3213988224 cites W2038504278 @default.
- W3213988224 cites W2040250419 @default.
- W3213988224 cites W2043530257 @default.
- W3213988224 cites W2043822368 @default.
- W3213988224 cites W2045241220 @default.
- W3213988224 cites W2045457035 @default.
- W3213988224 cites W2045653120 @default.
- W3213988224 cites W2045895711 @default.
- W3213988224 cites W2046020180 @default.
- W3213988224 cites W2046463738 @default.
- W3213988224 cites W2046585589 @default.
- W3213988224 cites W2048680477 @default.
- W3213988224 cites W2048701819 @default.
- W3213988224 cites W2053096589 @default.
- W3213988224 cites W2055313665 @default.
- W3213988224 cites W2056745327 @default.
- W3213988224 cites W2057420408 @default.
- W3213988224 cites W2059913727 @default.
- W3213988224 cites W2062078686 @default.
- W3213988224 cites W2062412252 @default.
- W3213988224 cites W2063959208 @default.
- W3213988224 cites W2066234893 @default.
- W3213988224 cites W2067199762 @default.
- W3213988224 cites W2069773823 @default.
- W3213988224 cites W2070799892 @default.
- W3213988224 cites W2074141001 @default.
- W3213988224 cites W2074889280 @default.
- W3213988224 cites W2074977276 @default.
- W3213988224 cites W2075732757 @default.
- W3213988224 cites W2076465532 @default.
- W3213988224 cites W2077577026 @default.
- W3213988224 cites W2085070983 @default.
- W3213988224 cites W2087296092 @default.
- W3213988224 cites W2089229823 @default.
- W3213988224 cites W2096412704 @default.
- W3213988224 cites W2096940705 @default.
- W3213988224 cites W2100682779 @default.
- W3213988224 cites W2103059478 @default.
- W3213988224 cites W2105813590 @default.
- W3213988224 cites W2106461550 @default.
- W3213988224 cites W2107210199 @default.
- W3213988224 cites W2108189527 @default.
- W3213988224 cites W2109513968 @default.
- W3213988224 cites W2110154453 @default.